Humanigen Archives - Inside Precision Medicine

Inside Precision Medicine Humanigen’s Lenzilumab Fails to Get EUA as COVID-19 Treatment

Antibodies responding to covid-19 coronavirus, illustration

Coronavirus

Humanigen’s Lenzilumab Fails to Get EUA as COVID-19 Treatment

September 14, 2021

Illustration of a torso of a patient showing the lungs being infected with SARS-CoV-2 virus, which can lead to acute respiratory distress syndrome (ARDS)

Coronavirus

Emergency Use Authorizations for COVID-19 Drugs Sought by Humanigen, NeuroRx

March 31, 2021

Antibodies responding to coronavirus particles, illustration

Coronavirus

Humanigen Attempts Revival via Battle Against COVID-19

September 8, 2020

Related Content

Timberlyne Therapeutics Launched Last Week with a $180 Million Series A Financing

Timberlyne Therapeutics Launched Last Week with a $180 Million Series A Financing

New Insights into T-Cell Role in Viral Defense Could Transform Vaccine Strategies

New Insights into T-Cell Role in Viral Defense Could Transform Vaccine Strategies

Dana-Farber Launches Center for RAS Therapeutics Focused on RAS-Driven Cancers

Dana-Farber Launches Center for RAS Therapeutics Focused on RAS-Driven Cancers

Large-Scale Genomic Analysis Improves Outcomes in 20 Cancer Types

Large-Scale Genomic Analysis Improves Outcomes in 20 Cancer Types